NCT07212816Not yet recruiting
Detection of Atrial Fibrillation Through Voice Signal Processing
Source: ClinicalTrials.gov · Last updated 8 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is testing a new technology that listens to a person's voice during short phone calls to help identify heart rhythm problems. The goal is to see if voice signal analysis can tell the difference between a normal rhythm (sinus rhythm) and an irregular rhythm (atrial fibrillation). We are enrolling adults scheduled for a standard heart procedure called cardioversion, which is used to reset the heart to a normal rhythm. Each participant will provide voice recordings through three short phone calls: before cardioversion, just after the procedure, and at a follow-up visit. Results will be compared with standard heart rhythm tests (electrocardiograms or ECGs). This research may lead to a simple, low-cost way to monitor heart rhythms remotely without requiring special devices.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 40 (estimated)
- First submitted
- 1 Oct 2025
- Start date
- Oct 2025
- Primary completion date
- Nov 2025
- Lead sponsor
- Vital Audio Inc
- Diseases
- Atrial fibrillation
- NCT number
- NCT07212816
What you commit to
- Study type: Observational
- Planned participants: 40
- From Oct 2025 to the primary completion date, Nov 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of a pacemaker
- History of dysphasia or difficulty with word finding
- History of vocal cord dysfunction
- Patient with atrial flutter as presenting arrhythmia
Other
- Patients who meet any of the following criteria must be excluded from this study:
- Planned transesophageal echocardiogram (TEE) with cardioversion
Who the study is looking for
- To participate in this study, patients must meet all of the following inclusion criteria:
- Diagnosis of atrial fibrillation and presenting for cardioversion at Allina Health in atrial fibrillation
- 3\. ≥ 18 years of age Written informed consent obtained from patient in English
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.